Hanlin Wang
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
RBFOX2 suppresses NETosis and glioma growth via 5hmC-dependent PDGFB decay.
Journal: Cell reports
Published: November 30, 2025
Bariatric surgery resolves MASH by enhancing MAT1A-dependent one-carbon metabolism.
Journal: Nature communications
Published: October 22, 2025
Discovery and optimization of Menin-MLL inhibitors targeting acute myeloid leukemia.
Journal: European journal of medicinal chemistry
Published: October 17, 2025
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases.
Journal: Nature
Published: July 20, 2025
GLS1-RNA Polymerase II Axis Mediates Glutamine-Dependent Hepatoprotective Effects on Alcoholic Liver Disease in High-Protein Diets.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 12, 2025
Skin-penetrating peptides derived from computational simulation improve transdermal absorption and facilitate topical treatment of melanoma.
Journal: Acta pharmaceutica Sinica. B
Published: January 22, 2025
Design and development of a series of 4-(piperazin-1-yl)pyrimidines as irreversible menin inhibitors.
Journal: European journal of medicinal chemistry
Published: August 19, 2024
Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia.
Journal: Science bulletin
Published: June 24, 2024
Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis.
Journal: Cell communication and signaling : CCS
Published: May 04, 2024
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 28, 2024
Macrophage SUCLA2 coupled glutaminolysis manipulates obesity through AMPK.
Journal: Nature communications
Published: February 10, 2024
HSV-1-induced N6-methyladenosine reprogramming via ICP0-mediated suppression of METTL14 potentiates oncolytic activity in glioma.
Journal: Cell reports
Published: December 25, 2023
Last Updated: 09/26/2026